US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 20.1000
- +0.3900+1.98%
Close Nov 22 16:00 ET
- 19.6512
- -0.4488-2.23%
Post 20:02 ET
106.08MMarket Cap-10151P/E (TTM)
20.2050High19.5409Low32.55KVolume19.8800Open19.7100Pre Close646.35KTurnover1.30%Turnover RatioLossP/E (Static)5.28MShares38.500052wk High21.45P/B50.20MFloat Cap1.369552wk Low--Dividend TTM2.50MShs Float240.0000Historical High--Div YieldTTM3.37%Amplitude1.3695Historical Low19.8580Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Monopar Therapeutics Stock Forum
Cash and Net Loss
Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.
Monopar project...
can anyone tell me which stock should I buy to get profit because the onse I've been had they're only giving return of 4 to 5%
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
No comment yet